Potential of nanoemulsions for intravenous delivery of rifampicin

Pharmazie

Volumn 63, Issue 11, 2008, Pages 806-811

  Ahmed, M ^a   Ramadan, W ^a   Rambhu, D ^a   Shakeel, Faiyaz ^a  

^a Al Arab Medical Sciences University   (Libyan Arab Jamahiriya)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ARTICLE; DRUG FORMULARY; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; EMULSION; IN VITRO STUDY; OSMOTIC PRESSURE; PHASE SEPARATION;

ANTIBIOTICS, ANTITUBERCULAR; CHROMATOGRAPHY, THIN LAYER; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; EXCIPIENTS; HYDROGEN-ION CONCENTRATION; INFUSIONS, INTRAVENOUS; NANOPARTICLES; OILS; OSMOTIC PRESSURE; POLYSORBATES; RIFAMPIN; SOLUBILITY; SURFACE-ACTIVE AGENTS; THERMODYNAMICS; VISCOSITY;

EID: 56749107618     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.8108     Document Type: Article

References (27)

1. Ali J, Ali N, Sultana Y, Baboota S, Shakeel F (2007) Development and validation of a stability indicating HPTLC method for analysis of antitubercular drugs. Acta Chromatogr 18: 168-179.
2. Baboota S, Shakeel F, Ahuja A, Ali J, Shafiq S (2007) Design development and evaluation of novel nanoemulsions formulations for transdermal potential of celecoxib. Acta Pharm 8: 316-332.
3. Craig DQM, Barker SA, Banning D, Booth SW (1995) An investigation into the mechanism of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int J Pharm 114: 103-110.
4. Doenicke AW, Roizen MF, Rau J, Kellerman W, Babl J (1996) Reducing pain during propofol injection: The role of the solvent. Anaesth Analg 82: 472-474.
5. Kawakami K, Yoshikawa T, Moroto Y, Kanaoka E, Takahashi K, Nishihara Y, Masuda K (2002) Microemulsion formulation for enhanced absorption of poorly soluble drugs I: prescription design. J Control Rel 81: 65-74.
6. Khoo SM, Humberstone AJ, Porter CLH, Edwards GA, Charman WN (1998) Formulation design and bioavailability assessment of lipid self-emulsifying formulations of halofantrine. Int J Pharm 167: 155-164.
7. Kim CK, Kim JH, Park KM, Oh KH, Oh U, Hwang SJ (1997) Preparation and evaluation of titrated extract of centella asiatica injection in the form of extemporaneous micellar solution. Int J Pharm 146: 63-70.
8. Klement W, Arndt JO (1991) Pain on IV injection of some anaesthetic agents is evoked by the unphysiological osmolality or pH of their formulations. Br J Anaesth 66: 189-195.
9. Lawrence MJ, Rees GD (2000) Microemulsion based media as novel drug delivery system. Adv Drug Deliv Rev 45: 89-121.
10. Lee JM, Park KM, Lim SJ, Lee MK, Kim CK (2002) Microemulsion formulations of clonixic acid: solubility enhancement and pain reduction. J Pharm Pharmacol 54: 43-49.
11. th edition., Royal Pharmaceutical Society of Great Britain, Londan, p. 1564-1585.
12. Park K, Kim CK (1999) Preparation and evaluation of flurbiprofen loaded microemulsion for parenteral delivery. Int J Pharm 181: 173-179.
13. Ping L, Ghosh A, Wagner RF, Krill S, Joshi YM, Serajuddin ATM (2005) Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int J Pharm 288: 27-34.
14. Pouten CW (1997) Formulation of self-emulsifying drug delivery systems. Adv Drug Del Rev 25: 47-58.
15. th edition., p. 649-652.
16. Rhee YS, Park CW, Nam TY, Shin YS, Chi SC, Park ES (2007) Formulation of parenteral microemulsion containing itraconazole. Arch Pharm Res 30: 114-123.
17. Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M (2007a) Design and development of oral oil in water ramipril nanoemulsion formulation: In vitro and in vivo assessment. J Biomed Nanotech 3: 28-44.
18. Shafiq S, Shakeel F, Talegaonkar S, Ali J, Baboota S, Ahuja A, Khar RK, Ali M (2007b) Formulation development and optimization using nanoemulsion technique: a technical note. AAPS Pharm Sci Tech 8: E 28.
19. Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M (2007c) Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm 66: 227-242.
20. Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M, Shafiq S (2007) Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS Pharm Sci Tech 8: E 104.
21. Shinoda K, Kunieda H (1983) Phase properties of emulsions: PIT and HLB. In: Schuster D (ed.) Encyclopedia of Emulsion Technology, Marcel Dekker, New York, p 337-367.
22. Shishoo CJ, Shah SA, Rathod IS, Kotecha JS, Shah PB (1999) Stability of rifampicin in dissolution medium in presence of isoniazid. Int J Pharm 190: 109-123.
23. Shishoo CJ, Shah SA, Rathod IS, Savale SS, Vora MJ (2001) Impaired bioavailability of rifampicin in presence of isoniazid from fixed dose combination formulation. Int J Pharm 228: 53-67.
24. Singh S, Mariappan TT, Sharda N, Kumar S, Chakraborti AK (2000) The reason for an increase decomposition of rifampicin in the presence of isoniazid under acidic conditions. Pharm Pharmacol Commun 6: 405-410.
25. Voncorswant C, Thoren P, Engestrom S (1998) Triglycerides based microemulsions for intravenous administration of sparingly soluble substances. J Pharm Sci 87: 201-208.
26. Vondardel O, Mebius C, Moosberg T, Svensson B (1983) Fat emulsion as a vehicle for diazepam. A study of 9492 patients. Br J Anaesth 55: 41-47.
27. Zhao X, Chen D, Gao P, Ding P, Li K (2005) Synthesis of ibuprofen eugenol ester and its microemulsion formulation for parenteral delivery. Chem Pharm Bull 53: 1246-1250.